105 research outputs found
Proteomic Evaluation of Neonatal Exposure to 2,2âČ,4,4âČ,5-Pentabromodiphenyl Ether
Exposure to the brominated flame retardant 2,2âČ,4,4âČ,5-pentabromodiphenyl ether (PBDE-99) during the brain growth spurt disrupts normal brain development in mice and results in disturbed spontaneous behavior in adulthood. The neurodevelopmental toxicity of PBDE-99 has been reported to affect the cholinergic and catecholaminergic systems. In this study we use a proteomics approach to study the early effect of PBDE-99 in two distinct regions of the neonatal mouse brain, the striatum and the hippocampus. A single oral dose of PBDE-99 (12 mg/kg body weight) or vehicle was administered to male NMRI mice on neonatal day 10, and the striatum and the hippocampus were isolated. Using two-dimensional fluorescence difference gel electrophoresis (2D-DIGE), we found 40 and 56 protein spots with significantly (p < 0.01) altered levels in the striatum and the hippocampus, respectively. We used matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDIâToFâMS) to determine the protein identity of 11 spots from the striatum and 10 from the hippocampus. We found that the levels of proteins involved in neurodegeneration and neuroplasticity (e.g., Gap-43/neuromodulin, stathmin) were typically altered in the striatum, and proteins involved in metabolism and energy production [e.g., α-enolase; Îł-enolase; ATP synthase, H(+) transporting, mitochondrial F(1) complex, ÎČ subunit (Atp5b); and α-synuclein] were typically altered in the hippocampus. Interestingly, many of the identified proteins have been linked to protein kinase C signaling. In conclusion, we identify responses to early exposure to PBDE-99 that could contribute to persistent neurotoxic effects. This study also shows the usefulness of proteomics to identify potential biomarkers of developmental neurotoxicity of organohalogen compounds
Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study
Bisphenol A and its analogues: A comprehensive review to identify and prioritize effect biomarkers for human biomonitoring
Human biomonitoring (HBM) studies have demonstrated widespread and daily exposure to bisphenol A (BPA).
Moreover, BPA structural analogues (e.g. BPS, BPF, BPAF), used as BPA replacements, are being increasingly
detected in human biological matrices. BPA and some of its analogues are classified as endocrine disruptors
suspected of contributing to adverse health outcomes such as altered reproduction and neurodevelopment,
obesity, and metabolic disorders among other developmental and chronic impairments. One of the aims of the
H2020 European Human Biomonitoring Initiative (HBM4EU) is the implementation of effect biomarkers at large
scales in future HBM studies in a systematic and standardized way, in order to complement exposure data with
mechanistically-based biomarkers of early adverse effects. This review aimed to identify and prioritize existing
biomarkers of effect for BPA, as well as to provide relevant mechanistic and adverse outcome pathway (AOP)
information in order to cover knowledge gaps and better interpret effect biomarker data. A comprehensive
literature search was performed in PubMed to identify all the epidemiologic studies published in the last 10 years
addressing the potential relationship between bisphenols exposure and alterations in biological parameters. A
total of 5716 references were screened, out of which, 119 full-text articles were analyzed and tabulated in detail.
This work provides first an overview of all epigenetics, gene transcription, oxidative stress, reproductive, glucocorticoid and thyroid hormones, metabolic and allergy/immune biomarkers previously studied. Then, promising effect biomarkers related to altered neurodevelopmental and reproductive outcomes including brainderived neurotrophic factor (BDNF), kisspeptin (KiSS), and gene expression of nuclear receptors are prioritized,
providing mechanistic insights based on in vitro, animal studies and AOP information. Finally, the potential of
omics technologies for biomarker discovery and its implications for risk assessment are discussed. To the best of
our knowledge, this is the first effort to comprehensively identify bisphenol-related biomarkers of effect for HBM
purposes.European Union Commission H2020-EJP-HBM4EU
733032HBM4EU Initiativ
The effect of type of femoral component fixation on mortality and morbidity after hip hemiarthroplasty:A systematic review and meta-analysis
Background: Hip hemiarthroplasty is a well-established treatment of displaced femoral neck fracture, although debate exists over whether cemented or uncemented fixation is superior. Uncemented prostheses have typically been used in younger, healthier patients and cemented prostheses in older patients with less-stable bone. Also, earlier research has suggested that bone cement has cytotoxic effects and may trigger cardiovascular and respiratory adverse events. Questions/Purposes: The aim of this systematic review and meta-analysis was to compare morbidity and mortality rates after cemented and uncemented hemiarthroplasty for the treatment of displaced femoral neck fractures in elderly patients. Methods: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched seven medical databases for randomized clinical trials and observational studies. We compared cemented and uncemented hemiarthroplasty using the Harris Hip Score (HHS), as well as measures of postoperative pain, mortality, and complications. Data were extracted and pooled as risk ratios or standardized mean difference with their corresponding 95% confidence intervals in a meta-analysis model. Results: The meta-analysis included 34 studies (12 randomized trials and 22 observational studies), with a total of 42,411 patients. In the pooled estimate, cemented hemiarthroplasty was associated with less risk of postoperative pain than uncemented hemiarthroplasty. There were no significant differences between groups regarding HHS or rates of postoperative mortality, pulmonary embolism, cardiac arrest, myocardial infarction, acute cardiac arrhythmia, or deep venous thrombosis. Conclusions: While we found that cemented hemiarthroplasty results in less postoperative pain than uncemented hemiarthroplasty in older patients with femoral neck fracture, the lack of significant differences in functional hip scores, mortality, and complications was surprising. Further high-level research is needed
Risk to human health related to the presence of perfluoroalkyl substances in food
Acknowledgements: The Panel wishes to thank the following for their support provided to this scientific output as Hearing experts: Klaus Abraham, Esben Budtz-JĂžrgensen, Tony Fletcher, Philippe Grandjean, Hans Mielke and Hans Rumke and EFSA staff members: Davide Arcella, Marco Binaglia, Petra Gergelova, Elena Rovesti and Marijke Schutte. The Panel wishes to acknowledge all European competent institutions, Member State bodies and other organisations that provided data for this scientific output. The Panel would also like to thank the following authors and co-authors for providing additional information in relation to their respective studies: Berit Granum, Margie M Peden-Adams, Thomas Webster.Peer reviewedPublisher PD
PPAR-Îł Agonist GW1929 But Not Antagonist GW9662 Reduces TBBPA-Induced Neurotoxicity in Primary Neocortical Cells
Arbetsterapi, interprofessionalitet och behov - aspekter pÄ vÀlfÀrdsteknik i kommunala Àldreboenden : En kvalitativ studie om arbetsterapeuters erfarenheter av anvÀndning av vÀlfÀrdsteknik för personer med demens
- âŠ